A

Alpha Cognition Inc
NASDAQ:ACOG

Watchlist Manager
Alpha Cognition Inc
NASDAQ:ACOG
Watchlist
Price: 10.53 USD -2.64% Market Closed
Market Cap: 168.7m USD

Relative Value

There is not enough data to reliably calculate the relative value of ACOG.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ACOG Relative Value
Base Case
Not Available
A
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.5
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.4
Industry
23.6
vs History
vs Industry
Median 3Y
-0.8
Median 5Y
-0.8
Industry
20.2
vs History
vs Industry
Median 3Y
-0.8
Median 5Y
-0.8
Industry
22.9
vs History
vs Industry
Median 3Y
5.5
Median 5Y
5.4
Industry
2.8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.7
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.6
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.4
Industry
4.9
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.4
Industry
4.9
vs History
vs Industry
Median 3Y
-0.5
Median 5Y
-0.5
Industry
5.4
vs History
vs Industry
Median 3Y
-0.5
Median 5Y
-0.5
Industry
4
vs History
vs Industry
Median 3Y
-16.6
Median 5Y
-16.9
Industry
5.1

Multiples Across Competitors

ACOG Competitors Multiples
Alpha Cognition Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Alpha Cognition Inc
NASDAQ:ACOG
9.9m USD 0 -0.4 -0.4 -0.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 980 524.7 -161 504.4 -196 117.9 -193 879.9
US
Abbvie Inc
NYSE:ABBV
338.3B USD 5.9 81.4 15.5 22.9
US
Amgen Inc
NASDAQ:AMGN
159.7B USD 4.7 26.9 14.4 23.8
US
Gilead Sciences Inc
NASDAQ:GILD
139.6B USD 4.9 23.4 10.2 14
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.4B USD 10.9 -122.7 26.1 27.4
US
Epizyme Inc
F:EPE
94.1B EUR 2 073.2 -529 -576.1 -560.7
AU
CSL Ltd
ASX:CSL
121.4B AUD 5.2 28.9 17.8 22.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
61.7B USD 4.4 13.7 12.3 13.8
US
Seagen Inc
F:SGT
39.3B EUR 20 -61.2 -66 -59.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
41.1B USD 17.5 -152.6 -683.9 -342.7
P/S Multiple
Revenue Growth P/S to Growth
CA
A
Alpha Cognition Inc
NASDAQ:ACOG
Average P/S: 3 398 267.1
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 980 524.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.9
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.9
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.9
10%
1.1
US
E
Epizyme Inc
F:EPE
2 073.2
N/A N/A
AU
CSL Ltd
ASX:CSL
5.2
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.4
4%
1.1
US
S
Seagen Inc
F:SGT
20
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.5
30%
0.6
P/E Multiple
Earnings Growth PEG
CA
A
Alpha Cognition Inc
NASDAQ:ACOG
Average P/E: 34.9
Negative Multiple: -0.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 504.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.4
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.9
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.4
189%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -122.7 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -529 N/A N/A
AU
CSL Ltd
ASX:CSL
28.9
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.7
7%
2
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.2 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -152.6 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
A
Alpha Cognition Inc
NASDAQ:ACOG
Average EV/EBITDA: 16
Negative Multiple: -0.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 117.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.5
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.4
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.1
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -576.1 N/A N/A
AU
CSL Ltd
ASX:CSL
17.8
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.3
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -683.9 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
A
Alpha Cognition Inc
NASDAQ:ACOG
Average EV/EBIT: 20.7
Negative Multiple: -0.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 879.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.9
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.8
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
14
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.4
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -560.7 N/A N/A
AU
CSL Ltd
ASX:CSL
22.2
14%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.8
11%
1.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -342.7 N/A N/A